Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PACS Stock Forecast 2025-2026
$10.43
Current Price
$1.62B
Market Cap
Buy 4
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to PACS Price Targets
+341.0%
To High Target of $46.00
+245.2%
To Median Target of $36.00
+130.1%
To Low Target of $24.00
PACS Price Momentum
+3.5%
1 Week Change
+13.9%
1 Month Change
-58.1%
1 Year Change
-20.4%
Year-to-Date Change
-76.3%
From 52W High of $43.92
+26.0%
From 52W Low of $8.28
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching PACS Group (PACS) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on PACS and similar high-potential opportunities.
Latest PACS Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, PACS has a bullish consensus with a median price target of $36.00 (ranging from $24.00 to $46.00). The overall analyst rating is Strong Buy (9.5/10). Currently trading at $10.43, the median forecast implies a 245.2% upside. This outlook is supported by 4 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from David Macdonald at Truist Securities, projecting a 341.0% upside. Conversely, the most conservative target is provided by Tao Qiu at Macquarie, suggesting a 130.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PACS Analyst Ratings
4
Buy
0
Hold
0
Sell
PACS Price Target Range
Low
$24.00
Average
$36.00
High
$46.00
Current: $10.43
Latest PACS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PACS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 6, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $32.00 |
| Jan 6, 2025 | Macquarie | Tao Qiu | Outperform | Maintains | $24.00 |
| Dec 17, 2024 | JP Morgan | Neutral | Downgrade | $0.00 | |
| Nov 18, 2024 | Stephens & Co. | Scott Fidel | Overweight | Maintains | $31.00 |
| Nov 6, 2024 | JP Morgan | Lisa Gill | Overweight | Reinstates | $40.00 |
| Oct 14, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $46.00 |
| Oct 9, 2024 | UBS | A.J. Rice | Buy | Initiates | $50.00 |
| Sep 11, 2024 | Citigroup | Jason Cassorla | Buy | Reinstates | $45.00 |
| Aug 15, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $44.00 |
| Aug 13, 2024 | Citigroup | Jason Cassorla | Buy | Maintains | $41.00 |
| Aug 13, 2024 | Stephens & Co. | Scott Fidel | Overweight | Maintains | $40.00 |
| Aug 13, 2024 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $40.00 |
| Jul 15, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $36.00 |
| Jun 28, 2024 | Macquarie | Tao Qiu | Outperform | Initiates | $35.00 |
| May 15, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $32.00 |
| May 15, 2024 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $32.00 |
| May 15, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $32.00 |
| May 14, 2024 | Stephens & Co. | Scott Fidel | Overweight | Reiterates | $31.00 |
| May 6, 2024 | JP Morgan | Calvin Sternick | Overweight | Initiates | $27.00 |
| May 6, 2024 | Stephens & Co. | Scott Fidel | Overweight | Initiates | $31.00 |
Pacs Group Inc. (PACS) Competitors
The following stocks are similar to PACS Group based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Pacs Group Inc. (PACS) Financial Data
Pacs Group Inc. has a market capitalization of $1.62B with a P/E ratio of 17.1x. The company generates $3.56B in trailing twelve-month revenue with a 2.6% profit margin.
Revenue growth is +29.1% quarter-over-quarter, while maintaining an operating margin of +0.1% and return on equity of +111.0%.
Valuation Metrics
Market Cap
$1.62B
Enterprise Value
$4.24B
P/E Ratio
17.1x
PEG Ratio
5.8x
Price/Sales
0.5x
Growth & Margins
Revenue Growth (YoY)
+29.1%
Gross Margin
+15.7%
Operating Margin
+0.1%
Net Margin
+2.6%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+4.6%
Current Ratio
1.7x
Debt/Equity
469.4x
ROE
+111.0%
ROA
+3.2%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Pacs Group Inc. (PACS) Business Model
About Pacs Group Inc.
What They Do
Provides integrated packaging solutions worldwide.
Business Model
The company manufactures innovative and sustainable packaging materials for various industries, including food and beverage, personal care, pharmaceuticals, and industrial goods. It generates revenue through the sale of these packaging solutions, leveraging advanced technology and eco-friendly materials to meet the demand for sustainability.
Additional Information
Pacs Group Inc. emphasizes research and development to create packaging that minimizes environmental impact while ensuring product integrity. It collaborates with leading manufacturers and retailers, enhancing its role in the global supply chain and positioning itself as a significant competitor in the packaging industry.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
32,433
CEO
Mr. Jason Murray
Country
United States
IPO Year
N/A
Website
pacs.comPacs Group Inc. (PACS) Latest News & Analysis
Latest News
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for PACS Group investors who purchased shares before April 11, 2024. More info can be found at bgandg.com/PACS.
Why It Matters
The investigation into PACS Group could indicate potential legal issues or financial discrepancies, impacting stock performance and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating claims for investors of PACS Group, Inc. (NYSE:PACS) who bought shares before April 11, 2024. More info available at bgandg.com/PACS.
Why It Matters
The investigation into PACS Group may indicate potential legal issues or financial mismanagement, affecting stock performance and investor sentiment.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors of PACS Group (NYSE:PACS) who bought securities before April 11, 2024. Further details are available on their website.
Why It Matters
The investigation into PACS Group may indicate potential legal or financial issues, impacting stock performance and investor sentiment significantly.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors of PACS Group (NYSE:PACS) who purchased shares before April 11, 2024. More info at bgandg.com/PACS.
Why It Matters
An investigation into PACS Group may indicate potential legal issues or financial instability, prompting concerns over the stock's future performance and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors of PACS Group (NYSE:PACS) who bought shares before April 11, 2024. More info is available at bgandg.com/PACS.
Why It Matters
The investigation into PACS Group may indicate potential legal issues or financial mismanagement, which could impact stock performance and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for PACS Group investors who bought shares before April 11, 2024. Interested parties can find more info on their website.
Why It Matters
The investigation into PACS Group may signal potential legal issues or financial irregularities, impacting stock performance and investor sentiment.
Source: Accesswire
Market Sentiment:
Neutral
Frequently Asked Questions About PACS Stock
What is Pacs Group Inc.'s (PACS) stock forecast for 2025?
Based on our analysis of 10 Wall Street analysts, Pacs Group Inc. (PACS) has a median price target of $36.00. The highest price target is $46.00 and the lowest is $24.00.
Is PACS stock a good investment in 2025?
According to current analyst ratings, PACS has 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $10.43. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PACS stock?
Wall Street analysts predict PACS stock could reach $36.00 in the next 12 months. This represents a 245.2% increase from the current price of $10.43. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Pacs Group Inc.'s business model?
The company manufactures innovative and sustainable packaging materials for various industries, including food and beverage, personal care, pharmaceuticals, and industrial goods. It generates revenue through the sale of these packaging solutions, leveraging advanced technology and eco-friendly materials to meet the demand for sustainability.
What is the highest forecasted price for PACS Pacs Group Inc.?
The highest price target for PACS is $46.00 from David Macdonald at Truist Securities, which represents a 341.0% increase from the current price of $10.43.
What is the lowest forecasted price for PACS Pacs Group Inc.?
The lowest price target for PACS is $24.00 from Tao Qiu at Macquarie, which represents a 130.1% increase from the current price of $10.43.
What is the overall PACS consensus from analysts for Pacs Group Inc.?
The overall analyst consensus for PACS is bullish. Out of 10 Wall Street analysts, 4 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $36.00.
How accurate are PACS stock price projections?
Stock price projections, including those for Pacs Group Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 12, 2025 10:59 AM UTC